Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...
Adjusted EBITDA, a non-GAAP metric for Q4 2025 totaled $6 million compared to $5 million in Q4 2024. This brings adjusted EBITDA for the full year 2025 to $16.8 million compared to $11.5 million in ...
News-Medical.Net on MSN
How conflicting MIC breakpoints distort antimicrobial resistance data
By Vijay Kumar Malesu Why mismatched resistance thresholds between CLSI and EUCAST could be masking the true scale of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results